zoledronic acid has been researched along with Back Pain in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Dedeyne, L; Dejaeger, M; Dupont, J; Gielen, E; Laurent, MR; Luyten, FP | 1 |
Gan, F; Ge, Y; Liu, B; Yu, H | 1 |
Han, K; Hu, H; Shen, Z; Sun, Y; Tang, L; Wang, Y; Wu, C; Yao, Y; Zhang, J | 1 |
Bokhari, SW; Jones, FM | 1 |
Anderson, KC; Bianchi, G; Richardson, PG | 1 |
Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M | 1 |
Black, D; Boonen, S; Cauley, JA; Cummings, SR; Hadji, P; Man, Z; Mesenbrink, P; Palermo, L; Reid, IR | 1 |
Andrada, E; Cánovas, V; Carrato, A; Guillén-Ponce, C; Guirado-Risueño, M; Martín Hidalgo, A; Molina, MA; Molina, MJ; Molina-Garrido, MJ; Mora, A; Pastor, E | 1 |
2 trial(s) available for zoledronic acid and Back Pain
Article | Year |
---|---|
Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures.
Topics: Aged; Aged, 80 and over; Back Pain; Bone Density Conservation Agents; Combined Modality Therapy; Female; Follow-Up Studies; Fractures, Compression; Humans; Kyphoplasty; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Retrospective Studies; Spinal Fractures; Treatment Outcome; Zoledronic Acid | 2018 |
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
Topics: Back Pain; Bed Rest; Bone Density Conservation Agents; Diphosphonates; Disabled Persons; Drug Administration Schedule; Female; Humans; Imidazoles; Multivariate Analysis; Prevalence; Probability; Risk Factors; Spinal Fractures; Zoledronic Acid | 2011 |
6 other study(ies) available for zoledronic acid and Back Pain
Article | Year |
---|---|
Vertebral fractures after denosumab cessation.
Topics: Back Pain; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Diagnosis, Differential; Drug Substitution; Female; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Risk Adjustment; Secondary Prevention; Spinal Fractures; Thoracic Vertebrae; Withholding Treatment; Zoledronic Acid | 2020 |
Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer.
Topics: Adult; Aged; Back Pain; Bone Density Conservation Agents; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Karnofsky Performance Status; Middle Aged; Osteolysis; Pain Measurement; Quality of Life; Retrospective Studies; Spinal Neoplasms; Surveys and Questionnaires; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vertebroplasty; Zoledronic Acid | 2013 |
Hyperammonemic encephalopathy in multiple myeloma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Boronic Acids; Bortezomib; Brain; Brain Edema; Coma; Cyclophosphamide; Dexamethasone; Diphosphonates; Fatal Outcome; Humans; Hyperammonemia; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteolysis; Pyrazines; Tomography, X-Ray Computed; Zoledronic Acid | 2014 |
Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy; Bone Density Conservation Agents; Bone Marrow; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Fatigue; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Immunoglobulin G; Immunoglobulin lambda-Chains; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Pyrazines; Referral and Consultation; Thalidomide; Translocation, Genetic; Transplantation, Autologous; Zoledronic Acid | 2014 |
Multimodal therapy for vertebral involvement of systemic mastocytosis.
Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Histamine; Humans; Hypotension; Imidazoles; Male; Mast Cells; Mastocytosis, Systemic; Osteoporosis; Postoperative Complications; Prednisolone; Pressure; Proto-Oncogene Proteins c-kit; Spinal Fractures; Spine; Treatment Outcome; Vertebroplasty; Zoledronic Acid | 2009 |
Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
Topics: Aged; Anemia; Back Pain; Bone Density Conservation Agents; Bone Neoplasms; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypertension; Imidazoles; Immunologic Factors; Interferon-alpha; Magnetic Resonance Imaging; Mastocytosis, Systemic; Osteolysis; Osteoporosis; Radionuclide Imaging; Zoledronic Acid | 2008 |